FDA Has Authority To Be Vague On Supplement GMP Standards, Court Rules
This article was originally published in The Tan Sheet
Executive Summary
FDA can set somewhat vague standards for dietary supplement firms' compliance with some good manufacturing practice regulations, according to a ruling in a complaint challenging the agency's authority to issue GMP requirements.
You may also be interested in...
FDA Veers From Guidance In Some Supplement Health Claim Decisions – Court
FDA made unreasonable demands with disclaimers for proposed qualified health claims for vitamin C and vitamin E to reduce the risk of cancer, according to a court ruling.
FDA Veers From Guidance In Some Supplement Health Claim Decisions – Court
FDA made unreasonable demands with disclaimers for proposed qualified health claims for vitamin C and vitamin E to reduce the risk of cancer, according to a court ruling.
FDA Veers From Guidance In Some Supplement Health Claim Decisions – Court
FDA made unreasonable demands with disclaimers for proposed qualified health claims for vitamin C and vitamin E to reduce the risk of cancer, according to a court ruling.